Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages

Atherosclerosis

Volumn 136, Issue 1, 1998, Pages 43-49

  Liu, Shang Xi ^a   Chen, Yuan ^a   Zhou, Mei ^a   Wan, Jennifer ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

J774.A1; Lipopolysaccharide; Nitric oxide; Oxidized cholesterol; Oxidized LDL

Indexed keywords

CHOLESTEROL; LINOLEIC ACID; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CHOLESTEROL; LINOLEIC ACID; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MACROPHAGES; MICE; NITRIC OXIDE; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0031822451     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00185-8     Document Type: Article

References (41)

1. Stuehr D.J., Griffith O.W. Mammalian nitric oxide syntheses. Adv Enzymol Relat Areas Mol Biol. 65:1992;287.
2. Nishida K., Harrison D.G., Navas J.P., Fisher A.A., Dockery S.P., Uematsu M. Molecular cloning and characterization of the constitutive bovine aortic endothelial nitric oxide synthase. J Clin Invest. 90:1990;2092.
3. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714.
4. Lamas S., Marsden P.A., Li G.K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA. 89:1992;6348.
5. Xie O.W., Cho H.J., Calayca J., Mumford R.D., Swiderek K.M. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225.
6. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1992;682.
7. Forstermann U., Pollock J.S., Schmidt H.H.H.W., Heller M., Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA. 88:1991;1788.
8. Bredt D.S., Hwang P.M., Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:1990;768.
9. Moncada S., Radmonski M.W., Palmer R.M. Endothelial derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol. 37:1988;2495.
10. Bath P.M., Hassall D.G., Gladwin A.M., Palmer R.M., Martin J.F. Nitric oxide and prostacyclin divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler Thromb. 11:1991;254.
11. Hibbs J.B. jr., Taintor R.R., Vavrin Z., Rachlin E.M. Nitric oxide: a cytotoxic activated macrophage effect on molecule. Biochem Biophys Res Commun. 157:1988;87.
12. Russe R., Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 175:1990;87.
13. Gross S.S., Jaffe E.A., Levi R., Kilbourn R.G. Cytokine-activated endothelial cells express an isotope of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun. 178:1991;823.
14. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmcol. 105:1992;575.
15. Stuehr D.J., Nathan C.F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 169:1989;1543.
16. Rees D.D., Cellek S., Palmer R.M.J., Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun. 173:1990;54d1.
17. Chester A.H., O'Neil G.S., Moncada S., Tadjkarimi S., Yacoub M.H. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet. 336:1990;897.
18. Cooki J.P., Singer A.H., Tsao P., Zera P., Rowan R.A., Billingham M.E. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 90:1992;1168.
19. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801.
20. Esterbaur H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 13:1992;341.
21. Bolton E.J., Jessup W., Stanley K.K., Dean R.T. Enhanced LDL oxidation by murine macrophage foam cells and their failure to secrete nitric oxide. Atheroselerosis. 106:1994;213.
22. Yang X., Cai B., Sciacca R.S., Cammen P.J. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circulation Res. 74(2):1994;318.
23. Chin J.H., Azhar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoprotein. J Clin Invest. 89:1992;10.
24. Liao J.K., Shin W.S., Lee W.Y., ClarK S.L. Oxidized low density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 270:1995;319.
25. Liu S.X., Zhou M., Chen Y., Wen W.Y., Sun M.J. Lipoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation. Atherosclerosis. 121:1996;55.
26. Schuh J., Fairclough G.F., Haschemeyer R.H. Oxygen mediated heterogeneity of apo-low density lipoprotein. Proc Natl Acad Sci USA. 75:1978;3173.
27. Woff S.P. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for the measurement of hydroperoxide. Methods Enzymol. 223:1994;182.
28. Basu S.K., Goldstein J.L., Anderson G.W., Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 73:1976;3178.
29. Liu S.X., Chen Y., Zhou M. Inhibitory effect of ebselen on the oxidation of low density lipoprotein. Redox Rep. 1:1995;357.
30. Lowry O.H., Rosebroug N., Farr A.L. Protein measurement with folin phenol regent. J Biol Chem. 193:1957;265.
31. 15N] nitrate in biological fluids. Anal Biochem. 126:1982;131.
32. Thomas J.P., Geiger P.G., Girotti A.W. Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. J Lipid Res. 34:1993;479.
33. Jialal I., Freeman D.A., Grundy S.M. Varying susceptibility of different low density lipoproteins to oxidative modification. Arterioscl Thromb. 11:1991;482.
34. Hughes H., Mathews B., Lenz M.L., Guyton J.R. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7β-hydrocholesterol. Arterioscl Thromb. 14:1994;1177.
35. Mori T.A., Croft K.D., Puddey I.B., Beilin L.J. Analysis of native and oxidized low-density lipoprotein oxysterols using gas chromatography-mass spectrometry with selective ion monitoring. Redox Rep. 2(1):1996;25.
36. Malden L.T., Chait A., Raines E.W., Ross R. The influence of oxidatively modified low density lipoprotein on expression of platelet-derived growth factor by human monocyte-derived macrophages. J Biol Chem. 266:1991;13901.
37. Hamilton T.A., Ma G.P., Chisolm G.M. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-a mRNA in stimulated murine peritoneal macrophages. J Immunol. 144:1990;2343.
38. Fong L.G., Fong T.A., Cooper A.D. Inhibition of lipopolysaccharide induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein. J Lipid Res. 32:1991;1899.
39. Thai S.F., Lewis J.G., Williams R.B., Johnson S.P., Adams D.O. Effect of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO and cytolysis of tumor cells. J Leukoc Biol. 57:1995;427.
40. Liao J.K. Inhibition of Gi protein by low density lipoprotein attenuates bradykinin-stimulated release of endothelial-derived nitric oxide. J Biol Chem. 269:1994;12987.
41. Smith L.L., Johnson B.H. Biological activities of oxysterols. Free Radic Biol Med. 7:1989;285.